119 related articles for article (PubMed ID: 1523613)
1. Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation.
Andersson TR; Sie P; Pelzer H; Aamodt LM; Nustad K; Abildgaard U
Thromb Res; 1992 Jun; 66(5):591-8. PubMed ID: 1523613
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation.
Noda A; Wada H; Kusiya F; Sakakura M; Onishi K; Nakatani K; Gabazza EC; Asahara N; Tsukada M; Nobori T; Shiku H
Clin Appl Thromb Hemost; 2002 Jul; 8(3):265-71. PubMed ID: 12361205
[TBL] [Abstract][Full Text] [Related]
3. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
[TBL] [Abstract][Full Text] [Related]
4. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
5. A microtitre plate ELISA to measure thrombin-antithrombin complex using pan-specific antibodies.
Boisclair MD; Lane DA
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):795-802. PubMed ID: 1489901
[TBL] [Abstract][Full Text] [Related]
6. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A
Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102
[TBL] [Abstract][Full Text] [Related]
7. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
Kobayashi T; Terao T
Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
[TBL] [Abstract][Full Text] [Related]
8. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
9. Laboratory determination of heparin cofactor II.
Ezenagu LC; Brandt JT
Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
[TBL] [Abstract][Full Text] [Related]
10. The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibitions.
Falanga A; Ofosu FA; Delaini F; Oldani E; Dewar L; Lui L; Barbui T
Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S19-23; discussion 59-64. PubMed ID: 7514451
[TBL] [Abstract][Full Text] [Related]
11. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
Tran TH; Zbinden B; Lämmle B; Duckert F
Semin Thromb Hemost; 1985 Oct; 11(4):342-6. PubMed ID: 3840916
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
13. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Abildgaard U; Larsen ML
Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
[TBL] [Abstract][Full Text] [Related]
14. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
Tran TH; Duckert F
Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
16. [Activities of antithrombin III and heparin cofactor II in patients with pathologic blood coagulation conditions].
Hirokawa S; Kaji T; Tazawa K; Fujimaki M; Hayashi T; Niiya K; Sakuragawa N
Rinsho Ketsueki; 1992 Mar; 33(3):281-7. PubMed ID: 1578630
[TBL] [Abstract][Full Text] [Related]
17. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
[TBL] [Abstract][Full Text] [Related]
18. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
Matsuo T; Matsuo M; Sugimoto T; Wanaka K
Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
[TBL] [Abstract][Full Text] [Related]
19. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure.
Tollefsen DM; Pestka CA
Blood; 1985 Oct; 66(4):769-74. PubMed ID: 4041618
[TBL] [Abstract][Full Text] [Related]
20. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
